Seeking Alpha

GlaxoSmithKline's (GSK) $3B hit from the DoJ earlier this week is being billed as the...

GlaxoSmithKline's (GSK) $3B hit from the DoJ earlier this week is being billed as the “largest health care fraud settlement in U.S. history... unprecedented in both size and scope.” And nobody cares. Why? Because investors know that over the past decade, the two drugs behind the scandal, Paxil an Wellbutrin, together brought in more than seven times the amount of the settlement. Paxil brought in close to $14B, and Wellbutrin $8.5B. As is frequently the case in cases of corporate misdoings, crime and punishment aren't always relative.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector